VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor

Current therapeutic anti-angiogenic biologics used for the treatment of pathological ocular angiogenesis such as in diabetic retinopathy and wet macular degeneration often lead to detrimental side effects due to their interference with normal blood vessel physiology. In this issue of EMBO Molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Favara, David M, Harris, Adrian L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Closeups
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023881/
https://www.ncbi.nlm.nih.gov/pubmed/24803395
http://dx.doi.org/10.1002/emmm.201404026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023881/
https://www.ncbi.nlm.nih.gov/pubmed/24803395
http://dx.doi.org/10.1002/emmm.201404026

Ejemplares similares